Tissue microarray validation: A methodologic study with special reference to lung cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 7, 2009, Pages 2014-2021

  Karlsson, Christina ^a   Bodin, Lennart ^b   Piehl Aulin, Karin ^a   Karlsson, Mats G ^a,b  

^a ÖREBRO UNIVERSITY   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROTEIN P53;

ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; SURGICAL APPROACH; TISSUE MICROARRAY; VALIDATION PROCESS;

ADENOCARCINOMA; BREAST NEOPLASMS; CARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG NEOPLASMS; MALE; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 67650462275     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-0743     Document Type: Article

References (33)

1. Battifora H. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab Invest 1866;55:244-8.
2. Kraaz W, Risberg B, Hussein A. Multiblock: an aid in diagnostic immunohistochemistry. J Clin Pathol 1988;41:1337.
3. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;4:844-7.
4. Eguíluz C, Viguera E, Millán L, Pérez J. Multitissue array review: a chronological description of tissue array techniques, applications and procedures. Pathol Res Pract 2006;202:561-8.
5. Rosen DG, Huang X, Deavers MT, Malpica A, Silva EG, Liu J. Validation of tissue microarray technology in ovarian carcinoma. Mod Pathol 2004;17:790-7.
6. Simon R, Sauter G. Tissue microarray for miniaturized high-throughput molecular profiling of tumors. Exp Hematol 2002;30:1365-72.
7. Hoos A, Urist MJ, Stojadinovic A, et al. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors. Am J Pathol 2001;158:1245-51.
8. Rubin MA, Dunn R, Strawderman M, Pienta KJ. Tissue microarray sampling strategy for prostate cancer biomarker analysis. Am J Surg Pathol 2002;26:312-9.
9. Zhang D, Salto-Tellez M, Putti TC, Do E, Koay ES. Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer. Mod Pathol 2003;16:79-84.
10. Beasley MB, Brambilla E, Travis WD. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 2005;40:90-7.
11. Gomaa W, Ke Y, Fujii H, Helliwell T. Tissue microarray of head and neck squamous carcinoma: validation of the methodology for the study of cutaneous fatty acid-binding protein, vascular endothelial growth factor, involucrin and Ki-67. Virchows Arch 2005;447:701-9.
12. Baas IO, Mulder JW, Offerhaus GJ, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 1994;172:5-12.
13. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943-9.
14. Dunn G. Design and analysis of reliability studies. New York: Oxford University Press; 1989. p. 34-5.
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;8:1:307-10.
16. Piantadosi S. Clinical trials. A methodological perspective. 2nd ed. Wiley-Interscience: 2005. p. 253, 267-8.
17. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
18. Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. 3rd ed. Wiley-Interscience; 2003. p. 598-610.
19. Bozzetti C, Franciosi V, Crafa P, et al. Biological variables in non-small cell lung cancer: comparison between immunocytochemical determinations on fine needle aspirates from surgical specimens and immunohistochemical determinations of tissue sections. Lung Cancer 2000;29:33-41.
20. Choi PJ, Yang DK, Son CH, Lee KE, Lee JI, Roh MS. Fascin immunoreactivity for preoperatively predicting lymph node metastases in peripheral adenocarcinoma of the lung 3 cm or less in diameter. Eur J Cardiothorac Surg 2006;30:538-42.
21. Donati V, Faviana P, Dell'omodarme, et al. Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer. Hum Pathol 2004;35:1347-52.
22. Ibrahim M. The alimentary tract (pilot) module. Immunocytochemistry 2007;5:191-4.
23. Fons G, Hasibuan SM, van der Velden J, ten Kate FJW. Validation of tissue microarray technology in endometrioid cancer of the endometrium. J Clin Pathol 2007;60:500-3.
24. Camp RL, Neumeister V, Rimm DL. A decade of tissue microarays: progress in the discovery and validation of cancer biomarkers. J Clin Oncol 2008;26:5630-7.
25. Gulmann C, Loring P, O'Grady A, Kay E. Miniature tissue microarrays for HercepTest standardisation and analysis. J Clin Pathol 2004;57:1229-31.
26. Egervari K, Szollosi Z, Nemes Z. Tissue microarray technology in breast cancer HER-2 diagnostics. Pathol Res Pract 2007;203:169-77.
27. Kyndi M, Sörensen FB, Knudsen H, et al. Tissue microarrays compared with whole sections and biochemical analyses. A subgroup analysis of DBCG82 b&c. Acta Oncol 2008;47:591-9.
28. Bubendorf L, Kolmer M, Kononen J, et al. Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst 1999;20:1758-64.
29. Nocito A, Bubendorf L, Tinner EM, et al. Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 2001;194:349-57.
30. Torhorst J, Bucher C, Kononen J. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001;159:2249-56.
31. Jeon YK, Sung SW, Chung JH, et al. Clinicopathologic features and prognostic implications of epidermal growth factor receptor (EGFR) gene copy number and protein expression in non-small cell lung cancer. Lung Cancer 2006;54:387-98.
32. Bubendorf L, Nocito A, Moch H, Sauter G. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 2001;195:72-9.
33. Packeisen J, Korsching E, Herbst H, Boecker W, Buerger H. Demystified. . .tissue microarray technology. Mol Pathol 2003;56:198-204.